Genertec Universal Medical Group Co Ltd - Shs Unitary 144A/Reg

HKSE:02666 (China)   Shs Unitary 144A/Reg S
HK$ 4.27 (-2.06%) Jun 20
3.94
P/B:
0.43
Market Cap:
HK$ 8.08B ($ 1.03B)
Enterprise V:
HK$ 60.60B ($ 7.76B)
Volume:
5.98M
Avg Vol (2M):
7.54M
Trade In:
PE Ratio PS Ratio PB Ratio Price-to-FCF Market Cap
Current and historical daily PE Ratio for Genertec Universal Medical Group Co Ltd ( ) from 2015 to Jun 20 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Genertec Universal Medical Group stock (HKSE:02666) PE ratio as of Jun 20 2024 is 3.94. More Details

Genertec Universal Medical Group Co Ltd (HKSE:02666) PE Ratio (TTM) Chart

To

Genertec Universal Medical Group Co Ltd (HKSE:02666) PE Ratio (TTM) Historical Data

Total 1229
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 14
Genertec Universal Medical Group PE Ratio (TTM) Historical Data
Date PE Ratio (TTM) Data Date PE Ratio (TTM) Data
2024-06-20 3.9 2024-04-15 4.4
2024-06-19 4.0 2024-04-12 4.4
2024-06-18 3.9 2024-04-11 4.4
2024-06-17 3.9 2024-04-10 4.2
2024-06-14 4.0 2024-04-09 4.2
2024-06-13 4.0 2024-04-08 4.0
2024-06-12 3.9 2024-04-05 3.9
2024-06-11 4.2 2024-04-03 4.0
2024-06-07 4.2 2024-04-02 4.1
2024-06-06 4.2 2024-03-28 3.9
2024-06-05 4.2 2024-03-27 3.9
2024-06-04 4.2 2024-03-26 3.9
2024-06-03 4.1 2024-03-25 3.9
2024-05-31 4.1 2024-03-22 3.9
2024-05-30 4.2 2024-03-21 3.9
2024-05-29 4.2 2024-03-20 3.9
2024-05-28 4.3 2024-03-19 3.9
2024-05-27 4.4 2024-03-18 3.9
2024-05-24 4.4 2024-03-15 3.9
2024-05-23 4.4 2024-03-14 4.0
2024-05-22 4.5 2024-03-13 4.0
2024-05-21 4.5 2024-03-12 4.0
2024-05-20 4.7 2024-03-11 3.9
2024-05-17 4.6 2024-03-08 3.9
2024-05-16 4.6 2024-03-07 3.9
2024-05-14 4.7 2024-03-06 3.9
2024-05-13 4.8 2024-03-05 3.9
2024-05-10 4.7 2024-03-04 3.9
2024-05-09 4.5 2024-03-01 3.9
2024-05-08 4.4 2024-02-29 4.0
2024-05-07 4.5 2024-02-28 3.9
2024-05-06 4.5 2024-02-27 4.0
2024-05-03 4.4 2024-02-26 4.0
2024-05-02 4.5 2024-02-23 4.0
2024-04-30 4.4 2024-02-22 4.0
2024-04-29 4.4 2024-02-21 4.0
2024-04-26 4.3 2024-02-20 3.9
2024-04-25 4.3 2024-02-19 3.9
2024-04-24 4.3 2024-02-16 3.8
2024-04-23 4.3 2024-02-15 3.7
2024-04-22 4.3 2024-02-14 3.7
2024-04-19 4.3 2024-02-09 3.7
2024-04-18 4.3 2024-02-08 3.8
2024-04-17 4.4 2024-02-07 3.8
2024-04-16 4.4 2024-02-06 3.8

Genertec Universal Medical Group Co Ltd (HKSE:02666) PE Ratio (TTM) Comparison

Company Market Cap(Mil) PE Ratio (TTM)

Business Description

Business Description

Description
Genertec Universal Medical Group Co Ltd is principally engaged in providing financing to its customers under finance lease arrangements, the provision of advisory services, the sale of medical equipment as well as leases under operating lease arrangements, and the provision of other services. The Group has two business segments; The finance business comprises direct finance leasing, sale-and-leaseback, factoring, operating leases, and advisory services, and Healthcare business comprises includes integrated healthcare services as well as specialties and healthcare industry business. Geographically, it derives a majority of its revenue from Mainland China.